This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Rensselaer Polytechnic Institute. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: The Innovations of Marc Douaisi
Introduction
Marc Douaisi is an accomplished inventor based in Troy, Michigan. He has made significant contributions to the field of biomedical engineering, particularly in the synthesis of heparin. His work focuses on creating biosynthetic alternatives that can meet the needs of medical applications.
Latest Patents
Marc Douaisi holds a patent for a biosynthetic heparin. This patent relates to the synthesis of heparin that may be bioequivalent to porcine USP Heparin Sodium. The innovative synthesis process involves three intermediates starting from heparosan, showcasing his expertise in biochemical engineering.
Career Highlights
Marc Douaisi is affiliated with Rensselaer Polytechnic Institute, where he continues to advance his research and development efforts. His work at this prestigious institution allows him to collaborate with other leading scientists and contribute to groundbreaking research in the field.
Collaborations
Some of his notable coworkers include Navdeep Grover and Payel Datta. Their collaborative efforts enhance the research environment and foster innovation in their projects.
Conclusion
Marc Douaisi's contributions to the field of biomedical engineering, particularly through his patent on biosynthetic heparin, highlight his role as an innovative inventor. His work continues to impact the medical community positively.